These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31608962)

  • 1. Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial.
    Ali M; Sur D; Kanungo S; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Khan AI; Zaman K; Marks F; Dutta S; Bhattacharya SK; Clemens JD
    Int Health; 2020 Jan; 12(1):36-42. PubMed ID: 31608962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis.
    Khanam F; Kim DR; Liu X; Voysey M; Pitzer VE; Zaman K; Pollard AJ; Qadri F; Clemens JD
    EClinicalMedicine; 2023 Apr; 58():101925. PubMed ID: 37090439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India.
    Ali M; Sur D; Kim DR; Kanungo S; Bhattacharya SK; Manna B; Ochiai RL; Clemens J
    Vaccine; 2011 Nov; 29(48):9051-6. PubMed ID: 21939716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial.
    Qadri F; Khanam F; Liu X; Theiss-Nyland K; Biswas PK; Bhuiyan AI; Ahmmed F; Colin-Jones R; Smith N; Tonks S; Voysey M; Mujadidi YF; Mazur O; Rajib NH; Hossen MI; Ahmed SU; Khan A; Rahman N; Babu G; Greenland M; Kelly S; Ireen M; Islam K; O'Reilly P; Scherrer KS; Pitzer VE; Neuzil KM; Zaman K; Pollard AJ; Clemens JD
    Lancet; 2021 Aug; 398(10301):675-684. PubMed ID: 34384540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for preventing typhoid fever.
    Fraser A; Goldberg E; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001261. PubMed ID: 17636661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of population-level protection conferred by a rotavirus vaccine using the 'fried-egg' approach in a rural setting in Bangladesh.
    Aziz AB; Zaman K; Kim DR; Park JY; Im J; Ali M; Ahmmed F; Islam MT; Khanam F; Chowdhury F; Ahmed T; Hoque M; Liu X; Pak GD; Tadesse BT; Jeon HJ; Kang S; Khan AI; Kim JH; Marks F; Qadri F; Clemens JD
    Vaccine; 2021 Sep; 39(40):5876-5882. PubMed ID: 34454788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
    Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
    Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata.
    Im J; Islam MT; Kim DR; Ahmmed F; Chon Y; Zaman K; Khan AI; Ali M; Sur D; Kanungo S; Dutta S; Bhattacharya SK; Dougan G; Holt KE; Marks F; Kim JH; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008530. PubMed ID: 32804950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Theiss-Nyland K; Qadri F; Colin-Jones R; Zaman K; Khanam F; Liu X; Voysey M; Khan A; Hasan N; Ashher F; Farooq YG; Pollard AJ; Clemens JD
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S74-S82. PubMed ID: 30845333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.
    Im J; Khanam F; Ahmmed F; Kim DR; Kang S; Tadesse BT; Chowdhury F; Ahmed T; Aziz AB; Hoque M; Islam MT; Park J; Liu X; Sur D; Pak G; Jeon HJ; Zaman K; Khan AI; Qadri F; Marks F; Kim JH; Clemens JD
    Am J Trop Med Hyg; 2022 Mar; 106(4):1149-1155. PubMed ID: 35385827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI; Ochiai RL; Clemens JD
    Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
    Capeding MR; Teshome S; Saluja T; Syed KA; Kim DR; Park JY; Yang JS; Kim YH; Park J; Jo SK; Chon Y; Kothari S; Yang SY; Ham DS; Ryu JH; Hwang HS; Mun JH; Lynch JA; Kim JH; Kim H; Excler JL; Sahastrabuddhe S
    Vaccine; 2018 Jun; 36(26):3794-3801. PubMed ID: 29776750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials.
    Deen J; Clemens JD
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S764-S769. PubMed ID: 34273168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
    Yang HH; Wu CG; Xie GZ; Gu QW; Wang BR; Wang LY; Wang HF; Ding ZS; Yang Y; Tan WS; Wang WY; Wang XC; Qin M; Wang JH; Tang HA; Jiang XM; Li YH; Wang ML; Zhang SL; Li GL
    Bull World Health Organ; 2001; 79(7):625-31. PubMed ID: 11477965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.